Replies to post #33615 on Lexaria Bioscience Corp (LEXX)

[AgentSmith]

Thanks for sharing Gaffer.

Some details must remain undisclosed for now and will be revealed at the appropriate times, but in other respects we clearly are trying to position the Company for non-dilutive injections of capital through strategic partners and other commercial relationships.

Hmmmm...!

Before 2022 ends, we expect to have at least one major regulatory advancement such as an IND program approval, or one major new industry partner.

Guess we'll see.

All in all, reads (to me, of course) like "moar research", with maaaybe someone on the sidelines quite interested in seeing how some of that research shakes-out.

Only my [naive] $0.02 as always.
Best o' luck to everyone here in 2022!